Plexus (NASDAQ:PLXS) Price Target Raised to $195.00

Plexus (NASDAQ:PLXS) had its price objective increased by Benchmark from $165.00 to $195.00 in a research report sent to investors on Wednesday, Marketbeat Ratings reports. Benchmark currently has a buy rating on the technology company’s stock.

Several other brokerages have also weighed in on PLXS. Stifel Nicolaus set a $150.00 price objective on shares of Plexus in a research report on Friday, October 24th. Needham & Company LLC upped their price target on shares of Plexus from $158.00 to $165.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Wall Street Zen cut shares of Plexus from a “buy” rating to a “hold” rating in a report on Saturday, November 22nd. Sidoti cut Plexus from a “buy” rating to a “neutral” rating and set a $150.00 price objective for the company. in a report on Friday, October 24th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Plexus in a research report on Thursday, January 22nd. Two research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $189.20.

Plexus Price Performance

Shares of NASDAQ PLXS opened at $199.33 on Wednesday. The company has a quick ratio of 0.77, a current ratio of 1.59 and a debt-to-equity ratio of 0.06. The business’s 50 day moving average price is $159.97 and its two-hundred day moving average price is $145.86. The company has a market cap of $5.33 billion, a PE ratio of 31.00 and a beta of 0.81. Plexus has a twelve month low of $103.43 and a twelve month high of $208.36.

Plexus (NASDAQ:PLXS) last released its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.77 by $0.01. The company had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.07 billion. Plexus had a return on equity of 12.39% and a net margin of 4.28%.The business’s revenue was up 9.6% on a year-over-year basis. During the same period last year, the firm posted $1.73 earnings per share. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. On average, analysts predict that Plexus will post 5.9 EPS for the current year.

Insider Activity at Plexus

In other Plexus news, COO Oliver K. Mihm sold 2,327 shares of the firm’s stock in a transaction on Tuesday, November 25th. The stock was sold at an average price of $143.18, for a total transaction of $333,179.86. Following the transaction, the chief operating officer owned 18,442 shares in the company, valued at $2,640,525.56. This trade represents a 11.20% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Karen Marie Rapp sold 500 shares of Plexus stock in a transaction on Friday, November 28th. The shares were sold at an average price of $143.47, for a total value of $71,735.00. Following the completion of the transaction, the director directly owned 7,665 shares of the company’s stock, valued at $1,099,697.55. This represents a 6.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 9,674 shares of company stock valued at $1,382,876. 1.78% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. AQR Capital Management LLC raised its stake in Plexus by 103.1% in the first quarter. AQR Capital Management LLC now owns 8,384 shares of the technology company’s stock valued at $1,074,000 after purchasing an additional 4,255 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Plexus by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,971 shares of the technology company’s stock valued at $2,046,000 after buying an additional 705 shares during the period. United Services Automobile Association acquired a new position in shares of Plexus in the 1st quarter valued at approximately $218,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Plexus by 12.9% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 79,584 shares of the technology company’s stock worth $10,197,000 after acquiring an additional 9,078 shares during the period. Finally, Wealth Enhancement Advisory Services LLC acquired a new stake in shares of Plexus during the 2nd quarter worth approximately $254,000. Institutional investors own 94.45% of the company’s stock.

More Plexus News

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Plexus raised Q2 FY2026 EPS guidance to $1.80–$1.95 versus the Street at ~$1.63, and issued higher revenue guidance — a direct fundamental catalyst supporting a higher valuation and nearby analyst upgrades.
• Positive Sentiment: Needham upgraded/raised its price target to $206 and reiterated a Buy rating, highlighting the stronger start to fiscal 2026 and supporting upside momentum. Needham raises PT to $206 (Benzinga)
• Positive Sentiment: Benchmark raised its price target to $195, another vote of confidence from the sell-side that helps buoy the stock. Benchmark boosts PT to $195
• Positive Sentiment: Company commentary and analyst notes point to program ramps and market-share gains that could drive >12% revenue growth in FY2026 — a growth trajectory that justifies multiple expansion. Seeking Alpha: >12% revenue growth potential
• Positive Sentiment: Analyst write-ups and a Yahoo deep-dive attribute the guidance upgrade to specific program ramps and new manufacturing wins — concrete operational drivers versus one-off items. Yahoo: Q4 deep dive — program ramps
• Positive Sentiment: Plexus reported Q1 EPS of $1.78 (beat by $0.01) and revenue up ~9.6% year-over-year — topline growth and a modest EPS beat help validate the raised guidance. Zacks: Q1 earnings beat
• Neutral Sentiment: Some media/analyst coverage remains mixed on valuation and near-term sustainability of growth — expect debate on how much of the guidance is driven by a few large program ramps versus broad-based demand. Globe & Mail: mixed analyst opinions
• Neutral Sentiment: Full earnings materials and the call transcript are available for investors who want line-item detail and management’s tone on sustainability of margins and program timing. Earnings call transcript (Seeking Alpha)

Plexus Company Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.